Fibroneer IPF - A new treatment for people with idiopathic pulmonary fibrosis

Chronic lung disease

Idiopathic pulmonary fibrosis (IPF) is a serious chronic disease that affects the tissue surrounding the air sacs in the lung.  Over time these changes can cause permanent scarring in the lungs, called fibrosis, that makes it more difficult to breathe.  Common symptoms are shortness of breath and coughing.

A new drug called BI1015550 has been developed to help reduce the decline in lung function and improve quality of life in people with IPF. This clinical trial evaluates whether it is safe and well tolerated by people with IPF, and tests whether it helps to reduce the impact of IPF on lung function.

Trial Status
Trial Phase
Phase 3 Drug Trial
Trial contact details
Contact Person
RIO Clinical Trials Unit
What you need to know

Who can take part?

You can take part in this study if you:

  • Have been diagnosed with Idiopathic Pulmonary Fibrosis by a doctor
  • Are 40 years of age or older

You may not take part if you are taking immunomodulatory medications or high dose prednisone for a lung condition.

What is involved for you?

If you consent to participate in this study, you will undertake the following tests, assessments and procedures:

  • Medical history and collection of demographic information
  • Health questionnaires
  • Physical exam
  • Electrocardiogram
  • Lung function tests
  • Blood tests
  • Pregnancy tests for women who can have children
  • Take two oral tablets twice a day containing study drug or placebo for one year.

Trial dates

March 2023 to November 2023

All research clinical trials news

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.



Mater launches trial of Australian-first flu vaccine

Stephanie Guilas has worked in many departments throughout Mater Hospital Brisbane, however, after 28 years of service, she found her true passion working within Mater Research’s Mothers and Babies...



Stephanie Guilas is improving outcomes for mums and bubs through research

Working as a research assistant in an immunology research lab, Yvonne Gautam learnt what a clinical trial was after being asked to set up a lab for a Phase Two clinical trial.



Clinical Trials Coordinator Yvonne Gautam is working towards creating better treatments for patients with diabetes

Displaying results 1-3 (of 16)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|